美国 · SEC FORM 4
LIFECORE BIOMEDICAL, INC. \DE\
LFCR · Nasdaq · CIK 0001005286 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
9 同一窗口内观察到的 Form 4 交易行
0 sales · 9 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-01-08 · Josephs Paul · $97.6K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Kiper Christopher S; Legion Partners Asset Management, LLC; Legion Partners Holdings, LLC; Legion Partners, L.P. I; Legion Partners, L.P. II; Legion Partners, LLC; White Raymond T.Director,TenPercentOwner
○
OBUS NELSONDirector
○
Aryeh JasonDirector
○
Schechter JoshuaDirector
○
Korenberg Matthew EDirector
○
Antunes Humberto CalheirosDirector
○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-01-08 · Josephs Paul.
近期 Form 4 活动
0买入
0卖出
11其他 Form 4 交易行
11SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他9 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,476,291
- 上期报告
- 2,669,844
- 日均成交量
- 605,555
- 回补天数
- 4.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-01-08 | Josephs Paul | 买入 (P) | Common Stock | 17,000 | USD 5.74 | USD 97,580 | SEC 申报 ↗ |
| 2024-10-03 | LANDES JOSHUA; OBUS NELSON; WYNNEFIELD CAPITAL INC; WYNNEFIELD CAPITAL MANAGEMENT LLC; WYNNEFIELD PARTNERS SMALL CAP VALUE LP; WYNNEFIELD PARTNERS SMALL CAP VALUE LP I; WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD; Wynnefield Capital, Inc. Profit Sharing Plan | 买入 (P) | Common Stock, $0.001 par value per share | 292,683 | USD 4.10 | USD 1,200,000 | SEC 申报 ↗ |
| 2024-10-03 | Kiper Christopher S; Legion Partners Asset Management, LLC; Legion Partners Holdings, LLC; Legion Partners, L.P. I; Legion Partners, L.P. II; Legion Partners, LLC; White Raymond T. | 买入 (P) | Common Stock | 1,463,414 | USD 4.10 | USD 5,999,997 | SEC 申报 ↗ |
| 2022-11-25 | LANDES JOSHUA; OBUS NELSON; WYNNEFIELD CAPITAL INC; WYNNEFIELD CAPITAL MANAGEMENT LLC; WYNNEFIELD PARTNERS SMALL CAP VALUE LP; WYNNEFIELD PARTNERS SMALL CAP VALUE LP I; WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD; Wynnefield Capital, Inc. Profit Sharing Plan | 买入 (P) | Common Stock, $0.001 par value per share | 627,746 | USD 7.97 | USD 5,003,136 | SEC 申报 ↗ |
| 2022-10-24 | LANDES JOSHUA; OBUS NELSON; WYNNEFIELD CAPITAL INC; WYNNEFIELD CAPITAL MANAGEMENT LLC; WYNNEFIELD PARTNERS SMALL CAP VALUE LP; WYNNEFIELD PARTNERS SMALL CAP VALUE LP I; WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD; Wynnefield Capital, Inc. Profit Sharing Plan | 买入 (P) | Common Stock, $0.001 par value per share | 250,000 | USD 8.09 | USD 2,022,500 | SEC 申报 ↗ |
| 2022-01-13 | LANDES JOSHUA; OBUS NELSON; WYNNEFIELD CAPITAL INC; WYNNEFIELD CAPITAL MANAGEMENT LLC; WYNNEFIELD PARTNERS SMALL CAP VALUE LP; WYNNEFIELD PARTNERS SMALL CAP VALUE LP I; WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD; Wynnefield Capital, Inc. Profit Sharing Plan | 买入 (P) | Common Stock, $0.001 par value per share | 87,400 | USD 10.42 | USD 910,582 | SEC 申报 ↗ |
| 2022-01-12 | Schechter Joshua | 买入 (P) | Common Stock | 10,000 | USD 10.39 | USD 103,940 | SEC 申报 ↗ |
| 2022-01-12 | LANDES JOSHUA; OBUS NELSON; WYNNEFIELD CAPITAL INC; WYNNEFIELD CAPITAL MANAGEMENT LLC; WYNNEFIELD PARTNERS SMALL CAP VALUE LP; WYNNEFIELD PARTNERS SMALL CAP VALUE LP I; WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD; Wynnefield Capital, Inc. Profit Sharing Plan | 买入 (P) | Common Stock, $0.001 par value per share | 300,000 | USD 10.41 | USD 3,123,000 | SEC 申报 ↗ |
| 2021-04-20 | Walsh Patrick D | 买入 (P) | Common Stock | 10,000 | USD 11.26 | USD 112,600 | SEC 申报 ↗ |
| 2021-04-19 | Morberg John D | 买入 (P) | Common Stock | 2,000 | USD 11.05 | USD 22,100 | SEC 申报 ↗ |
| 2021-04-16 | Morberg John D | 买入 (P) | Common Stock | 2,000 | USD 11.08 | USD 22,160 | SEC 申报 ↗ |
| 2021-04-15 | Morberg John D | 买入 (P) | Common Stock | 2,000 | USD 10.98 | USD 21,960 | SEC 申报 ↗ |
| 2021-04-14 | Morberg John D | 买入 (P) | Common Stock | 2,000 | USD 10.64 | USD 21,280 | SEC 申报 ↗ |
| 2021-04-14 | Hall James G | 买入 (P) | Common Stock | 10,000 | USD 10.62 | USD 106,200 | SEC 申报 ↗ |
| 2021-04-14 | Bolles Albert D. | 买入 (P) | Common Stock | 9,000 | USD 10.61 | USD 95,490 | SEC 申报 ↗ |
Form 4 申报证据
11 transaction lines in the latest 365-day window; 191 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Kiper Christopher S; Legion Partners Asset Management, LLC; Legion Partners Holdings, LLC; Legion Partners, L.P. I; Legion Partners, L.P. II; Legion Partners, LLC; White Raymond T. | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | Schechter Joshua | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | OBUS NELSON | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (11 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Kiper Christopher S; Legion Partners Asset Management, LLC; Legion Partners Holdings, LLC; Legion Partners, L.P. I; Legion Partners, L.P. II; Legion Partners, LLC; White Raymond T. | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | Schechter Joshua | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | OBUS NELSON | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | Korenberg Matthew E | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | Johnson Paul Harold | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | HOUDE LOVAS KATRINA | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | Aryeh Jason | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | Antunes Humberto Calheiros | 奖励／授予 (A) | Common Stock | 25,907 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Josephs Paul | 代扣税 (F) | Common Stock | 40,413 | USD 4.57 | USD 184,687 | SEC 申报 ↗ |
| 2026-04-14 | Salus Thomas D. | 代扣税 (F) | Common Stock | 24,645 | USD 5.20 | USD 128,154 | SEC 申报 ↗ |
| 2026-03-02 | Salus Thomas D. | 奖励／授予 (A) | Common Stock | 30,000 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LFCR |
| CIK | 0001005286 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 191 transaction lines from 2020-01-16 to 2026-06-04 43 P purchase lines · 10 S sale lines · 138 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.